The key difference between cytotoxic T cells among patients with early and late asthma was the combination of a dramatic increase in the proportion of double-positive cells with a significant decrease in TNFR2 number in late disease in both the total pool of CD8+ cells and in activated CD8+CD25+ cells. Here, TNFRSF1B is linked to asthma.